[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Molecular Diagnostics Cancer Industry Research Report 2020, Forecast to 2025

August 2020 | 132 pages | ID: G3D4FB6DEC4BEN
WKinformation

US$ 2,560.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The Molecular Diagnostics Cancer market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Molecular Diagnostics Cancer is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Molecular Diagnostics Cancer industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Molecular Diagnostics Cancer by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Molecular Diagnostics Cancer market are discussed.

The market is segmented by types:
  • Pharmacogenomic Diagnosis
  • Liquid Biopsy
  • Other
It can be also divided by applications:
  • Respiratory Cancer
  • Cancer of Digestive System
  • Cancer of Urinary System
  • Cancer of Circulatory System
  • Motor System Cancer
  • Reproductive System Cancer
  • Other
And this report covers the historical situation, present status and the future prospects of the global Molecular Diagnostics Cancer market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.
  • Roche
  • Invitae
  • Abbott Laboratories
  • Danaher
  • MDxHealth
  • Siemens
  • Thermo Fisher Scientific
  • AstraZeneca
  • ICON Plc
  • PlexBio
  • Foundation Medicine
  • CytoTrack
  • Guardant Health
  • Luminex
  • 10X Genomics
  • Merck
  • Biocartis
  • GenomOncology
  • Biodesix
  • Bio-Techne
Report Includes:
  • xx data tables and xx additional tables
  • An overview of global Molecular Diagnostics Cancer market
  • An detailed key players analysis across regions
  • Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
  • Insights into regulatory and environmental developments
  • Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Molecular Diagnostics Cancer market
  • Profiles of major players in the industry, including Roche, Invitae, Abbott Laboratories, Danaher, MDxHealth.....
Research Objectives
  • To study and analyze the global Molecular Diagnostics Cancer consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
  • To understand the structure of Molecular Diagnostics Cancer market by identifying its various subsegments.
  • Focuses on the key global Molecular Diagnostics Cancer manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
  • To analyze the Molecular Diagnostics Cancer with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Molecular Diagnostics Cancer submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
Global Molecular Diagnostics Cancer Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Molecular Diagnostics Cancer Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 MOLECULAR DIAGNOSTICS CANCER INDUSTRY OVERVIEW

2.1 Global Molecular Diagnostics Cancer Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Molecular Diagnostics Cancer Global Import Market Analysis
  2.1.2 Molecular Diagnostics Cancer Global Export Market Analysis
  2.1.3 Molecular Diagnostics Cancer Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 Pharmacogenomic Diagnosis
  2.2.2 Liquid Biopsy
  2.2.3 Other
2.3 Market Analysis by Application
  2.3.1 Respiratory Cancer
  2.3.2 Cancer of Digestive System
  2.3.3 Cancer of Urinary System
  2.3.4 Cancer of Circulatory System
  2.3.5 Motor System Cancer
  2.3.6 Reproductive System Cancer
  2.3.7 Other
2.4 Global Molecular Diagnostics Cancer Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Molecular Diagnostics Cancer Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Molecular Diagnostics Cancer Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Molecular Diagnostics Cancer Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Molecular Diagnostics Cancer Manufacturer Market Share
  2.4.5 Top 10 Molecular Diagnostics Cancer Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Molecular Diagnostics Cancer Market
  2.4.7 Key Manufacturers Molecular Diagnostics Cancer Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Molecular Diagnostics Cancer Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Molecular Diagnostics Cancer Industry Impact
  2.7.1 How the Covid-19 is Affecting the Molecular Diagnostics Cancer Industry
  2.7.2 Molecular Diagnostics Cancer Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Molecular Diagnostics Cancer Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Molecular Diagnostics Cancer Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL MOLECULAR DIAGNOSTICS CANCER MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Molecular Diagnostics Cancer Sales Market Share by Region
4.2 Global Molecular Diagnostics Cancer Revenue Market Share by Region (2015-2019)
4.3 Global Molecular Diagnostics Cancer Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Molecular Diagnostics Cancer Market Size Detail
  4.4.1 North America Molecular Diagnostics Cancer Sales Growth Rate (2015-2020)
  4.4.2 North America Molecular Diagnostics Cancer Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Molecular Diagnostics Cancer Market Size Detail
  4.5.1 Europe Molecular Diagnostics Cancer Sales Growth Rate (2015-2020)
  4.5.2 Europe Molecular Diagnostics Cancer Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Molecular Diagnostics Cancer Market Size Detail
  4.6.1 Japan Molecular Diagnostics Cancer Sales Growth Rate (2015-2020)
  4.6.2 Japan Molecular Diagnostics Cancer Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Molecular Diagnostics Cancer Market Size Detail
  4.7.1 China Molecular Diagnostics Cancer Sales Growth Rate (2015-2020)
  4.7.2 China Molecular Diagnostics Cancer Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL MOLECULAR DIAGNOSTICS CANCER MARKET SEGMENT BY TYPE

5.1 Global Molecular Diagnostics Cancer Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Molecular Diagnostics Cancer Sales and Market Share by Type (2015-2020)
  5.1.2 Global Molecular Diagnostics Cancer Revenue and Market Share by Type (2015-2020)
5.2 Pharmacogenomic Diagnosis Sales Growth Rate and Price
  5.2.1 Global Pharmacogenomic Diagnosis Sales Growth Rate (2015-2020)
  5.2.2 Global Pharmacogenomic Diagnosis Price (2015-2020)
5.3 Liquid Biopsy Sales Growth Rate and Price
  5.3.1 Global Liquid Biopsy Sales Growth Rate (2015-2020)
  5.3.2 Global Liquid Biopsy Price (2015-2020)
5.4 Other Sales Growth Rate and Price
  5.4.1 Global Other Sales Growth Rate (2015-2020)
  5.4.2 Global Other Price (2015-2020)

6 GLOBAL MOLECULAR DIAGNOSTICS CANCER MARKET SEGMENT BY APPLICATION

6.1 Global Molecular Diagnostics CancerSales Market Share by Application (2015-2020)
6.2 Respiratory Cancer Sales Growth Rate (2015-2020)
6.3 Cancer of Digestive System Sales Growth Rate (2015-2020)
6.4 Cancer of Urinary System Sales Growth Rate (2015-2020)
6.5 Cancer of Circulatory System Sales Growth Rate (2015-2020)
6.6 Motor System Cancer Sales Growth Rate (2015-2020)
6.7 Reproductive System Cancer Sales Growth Rate (2015-2020)
6.8 Other Sales Growth Rate (2015-2020)

7 GLOBAL MOLECULAR DIAGNOSTICS CANCER MARKET FORECAST

7.1 Global Molecular Diagnostics Cancer Sales, Revenue Forecast
  7.1.1 Global Molecular Diagnostics Cancer Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Molecular Diagnostics Cancer Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Molecular Diagnostics Cancer Price and Trend Forecast (2020-2025)
7.2 Global Molecular Diagnostics Cancer Sales Forecast by Region (2020-2025)
  7.2.1 North America Molecular Diagnostics Cancer Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Molecular Diagnostics Cancer Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Molecular Diagnostics Cancer Production, Revenue Forecast (2020-2025)
  7.2.4 China Molecular Diagnostics Cancer Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF MOLECULAR DIAGNOSTICS CANCER INDUSTRY KEY MANUFACTURERS

8.1 Roche
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 Roche Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 Roche News
8.2 Invitae
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Invitae Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Invitae News
8.3 Abbott Laboratories
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Abbott Laboratories Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Abbott Laboratories News
8.4 Danaher
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 Danaher Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 Danaher News
8.5 MDxHealth
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 MDxHealth Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 MDxHealth News
8.6 Siemens
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 Siemens Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 Siemens News
8.7 Thermo Fisher Scientific
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Thermo Fisher Scientific News
8.8 AstraZeneca
  8.8.1 Company Details
  8.8.2 Product Information
  8.8.3 AstraZeneca Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.8.4 Main Business Overview
  8.8.5 AstraZeneca News
8.9 ICON Plc
  8.9.1 Company Details
  8.9.2 Product Information
  8.9.3 ICON Plc Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.9.4 Main Business Overview
  8.9.5 ICON Plc News
8.10 PlexBio
  8.10.1 Company Details
  8.10.2 Product Information
  8.10.3 PlexBio Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.10.4 Main Business Overview
  8.10.5 PlexBio News
8.11 Foundation Medicine
  8.11.1 Company Details
  8.11.2 Product Information
  8.11.3 Foundation Medicine Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.11.4 Main Business Overview
  8.11.5 Foundation Medicine News
8.12 CytoTrack
  8.12.1 Company Details
  8.12.2 Product Information
  8.12.3 CytoTrack Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.12.4 Main Business Overview
  8.12.5 CytoTrack News
8.13 Guardant Health
  8.13.1 Company Details
  8.13.2 Product Information
  8.13.3 Guardant Health Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.13.4 Main Business Overview
  8.13.5 Guardant Health News
8.14 Luminex
  8.14.1 Company Details
  8.14.2 Product Information
  8.14.3 Luminex Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.14.4 Main Business Overview
  8.14.5 Luminex News
8.15 10X Genomics
  8.15.1 Company Details
  8.15.2 Product Information
  8.15.3 10X Genomics Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.15.4 Main Business Overview
  8.15.5 10X Genomics News
8.16 Merck
  8.16.1 Company Details
  8.16.2 Product Information
  8.16.3 Merck Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.16.4 Main Business Overview
  8.16.5 Merck News
8.17 Biocartis
  8.17.1 Company Details
  8.17.2 Product Information
  8.17.3 Biocartis Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.17.4 Main Business Overview
  8.17.5 Biocartis News
8.18 GenomOncology
  8.18.1 Company Details
  8.18.2 Product Information
  8.18.3 GenomOncology Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.18.4 Main Business Overview
  8.18.5 GenomOncology News
8.19 Biodesix
  8.19.1 Company Details
  8.19.2 Product Information
  8.19.3 Biodesix Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.19.4 Main Business Overview
  8.19.5 Biodesix News
8.20 Bio-Techne
  8.20.1 Company Details
  8.20.2 Product Information
  8.20.3 Bio-Techne Molecular Diagnostics Cancer Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.20.4 Main Business Overview
  8.20.5 Bio-Techne News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX
LIST OF TABLES AND FIGURES

Figure Molecular Diagnostics Cancer Picture
Figure Research Programs/Design for This Report
Figure Global Molecular Diagnostics Cancer Market by Regions (2019)
Table Global Market Molecular Diagnostics Cancer Comparison by Regions (M USD) 2019-2025
Table Global Molecular Diagnostics Cancer Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Molecular Diagnostics Cancer by Type in 2019
Figure Pharmacogenomic Diagnosis Picture
Figure Liquid Biopsy Picture
Figure Other Picture
Table Global Molecular Diagnostics Cancer Sales by Application (2019-2025)
Figure Global Molecular Diagnostics Cancer Sales Market Share by Application in 2019
Figure Respiratory Cancer Picture
Figure Cancer of Digestive System Picture
Figure Cancer of Urinary System Picture
Figure Cancer of Circulatory System Picture
Figure Motor System Cancer Picture
Figure Reproductive System Cancer Picture
Figure Other Picture
Table Global Molecular Diagnostics Cancer Sales by Manufacturer (2018-2020)
Figure Global Molecular Diagnostics Cancer Sales Market Share by Manufacturer in 2019
Table Global Molecular Diagnostics Cancer Revenue by Manufacturer (2018-2020)
Figure Global Molecular Diagnostics Cancer Revenue Market Share by Manufacturer in 2019
Table Global Molecular Diagnostics Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Molecular Diagnostics Cancer Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Molecular Diagnostics Cancer Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Molecular Diagnostics Cancer Market
Table Key Manufacturers Molecular Diagnostics Cancer Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Molecular Diagnostics Cancer
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Molecular Diagnostics Cancer Sales (K Units) by Region (2015-2020)
Table Global Molecular Diagnostics Cancer Sales Market Share by Region (2015-2019)
Figure Global Molecular Diagnostics Cancer Sales Market Share by Region (2015-2019)
Figure Global Molecular Diagnostics Cancer Sales Market Share by Region in 2018
Table Global Molecular Diagnostics Cancer Revenue (Million US$) by Region (2015-2020)
Table Global Molecular Diagnostics Cancer Revenue Market Share by Region (2015-2020)
Figure Global Molecular Diagnostics Cancer Revenue Market Share by Region (2015-2020)
Figure Global Molecular Diagnostics Cancer Revenue Market Share by Region in 2019
Table Global Molecular Diagnostics Cancer Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Molecular Diagnostics Cancer Sales (K Units) Growth Rate (2015-2020)
Table North America Molecular Diagnostics Cancer Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Molecular Diagnostics Cancer Sales (K Units) Growth Rate (2015-2020)
Table Europe Molecular Diagnostics Cancer Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Molecular Diagnostics Cancer Sales (K Units) Growth Rate (2015-2020)
Table Japan Molecular Diagnostics Cancer Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Molecular Diagnostics Cancer Sales (K Units) Growth Rate (2015-2020)
Table China Molecular Diagnostics Cancer Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Molecular Diagnostics Cancer Sales by Type (2015-2020)
Table Global Molecular Diagnostics Cancer Sales Market Share by Type (2015-2020)
Figure Global Molecular Diagnostics Cancer Sales Market Share by Type in 2019
Table Global Molecular Diagnostics Cancer Revenue by Type (2015-2020)
Table Global Molecular Diagnostics Cancer Revenue Market Share by Type (2015-2020)
Figure Global Molecular Diagnostics Cancer Revenue Market Share by Type in 2019
Figure Global Pharmacogenomic Diagnosis Sales Growth Rate (2015-2020)
Figure Global Pharmacogenomic Diagnosis Price (2015-2020)
Figure Global Liquid Biopsy Sales Growth Rate (2015-2020)
Figure Global Liquid Biopsy Price (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global Other Price (2015-2020)
Table Global Molecular Diagnostics Cancer Sales by Application (2015-2020)
Table Global Molecular Diagnostics Cancer Sales Market Share by Application (2015-2020)
Figure Global Molecular Diagnostics Cancer Sales Market Share by Application in 2019
Figure Global Respiratory Cancer Sales Growth Rate (2015-2020)
Figure Global Cancer of Digestive System Sales Growth Rate (2015-2020)
Figure Global Cancer of Urinary System Sales Growth Rate (2015-2020)
Figure Global Cancer of Circulatory System Sales Growth Rate (2015-2020)
Figure Global Motor System Cancer Sales Growth Rate (2015-2020)
Figure Global Reproductive System Cancer Sales Growth Rate (2015-2020)
Figure Global Other Sales Growth Rate (2015-2020)
Figure Global Molecular Diagnostics Cancer Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Molecular Diagnostics Cancer Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Molecular Diagnostics Cancer Price and Trend Forecast (2020-2025)
Table Global Molecular Diagnostics Cancer Sales (K Units) Forecast by Region (2020-2025)
Figure Global Molecular Diagnostics Cancer Production Market Share Forecast by Region (2020-2025)
Figure North America Molecular Diagnostics Cancer Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Molecular Diagnostics Cancer Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Molecular Diagnostics Cancer Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Molecular Diagnostics Cancer Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Molecular Diagnostics Cancer Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Molecular Diagnostics Cancer Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Molecular Diagnostics Cancer Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Molecular Diagnostics Cancer Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table Roche Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of Roche
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure Roche Molecular Diagnostics Cancer Market Share (2018-2020)
Table Roche Main Business
Table Roche Recent Development
Table Invitae Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of Invitae
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure Invitae Molecular Diagnostics Cancer Market Share (2018-2020)
Table Invitae Main Business
Table Invitae Recent Development
Table Abbott Laboratories Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of Abbott Laboratories
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure Abbott Laboratories Molecular Diagnostics Cancer Market Share (2018-2020)
Table Abbott Laboratories Main Business
Table Abbott Laboratories Recent Development
Table Danaher Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of Danaher
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure Danaher Molecular Diagnostics Cancer Market Share (2018-2020)
Table Danaher Main Business
Table Danaher Recent Development
Table MDxHealth Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of MDxHealth
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure MDxHealth Molecular Diagnostics Cancer Market Share (2018-2020)
Table MDxHealth Main Business
Table MDxHealth Recent Development
Table Siemens Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of Siemens
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure Siemens Molecular Diagnostics Cancer Market Share (2018-2020)
Table Siemens Main Business
Table Siemens Recent Development
Table Thermo Fisher Scientific Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of Thermo Fisher Scientific
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure Thermo Fisher Scientific Molecular Diagnostics Cancer Market Share (2018-2020)
Table Thermo Fisher Scientific Main Business
Table Thermo Fisher Scientific Recent Development
Table AstraZeneca Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of AstraZeneca
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure AstraZeneca Molecular Diagnostics Cancer Market Share (2018-2020)
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table ICON Plc Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of ICON Plc
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure ICON Plc Molecular Diagnostics Cancer Market Share (2018-2020)
Table ICON Plc Main Business
Table ICON Plc Recent Development
Table PlexBio Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of PlexBio
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure PlexBio Molecular Diagnostics Cancer Market Share (2018-2020)
Table PlexBio Main Business
Table PlexBio Recent Development
Table Foundation Medicine Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of Foundation Medicine
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure Foundation Medicine Molecular Diagnostics Cancer Market Share (2018-2020)
Table Foundation Medicine Main Business
Table Foundation Medicine Recent Development
Table CytoTrack Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of CytoTrack
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure CytoTrack Molecular Diagnostics Cancer Market Share (2018-2020)
Table CytoTrack Main Business
Table CytoTrack Recent Development
Table Guardant Health Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of Guardant Health
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure Guardant Health Molecular Diagnostics Cancer Market Share (2018-2020)
Table Guardant Health Main Business
Table Guardant Health Recent Development
Table Luminex Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of Luminex
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure Luminex Molecular Diagnostics Cancer Market Share (2018-2020)
Table Luminex Main Business
Table Luminex Recent Development
Table 10X Genomics Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of 10X Genomics
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure 10X Genomics Molecular Diagnostics Cancer Market Share (2018-2020)
Table 10X Genomics Main Business
Table 10X Genomics Recent Development
Table Merck Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of Merck
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure Merck Molecular Diagnostics Cancer Market Share (2018-2020)
Table Merck Main Business
Table Merck Recent Development
Table Biocartis Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of Biocartis
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure Biocartis Molecular Diagnostics Cancer Market Share (2018-2020)
Table Biocartis Main Business
Table Biocartis Recent Development
Table GenomOncology Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of GenomOncology
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure GenomOncology Molecular Diagnostics Cancer Market Share (2018-2020)
Table GenomOncology Main Business
Table GenomOncology Recent Development
Table Biodesix Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of Biodesix
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure Biodesix Molecular Diagnostics Cancer Market Share (2018-2020)
Table Biodesix Main Business
Table Biodesix Recent Development
Table Bio-Techne Company Profile
Figure Molecular Diagnostics Cancer Product Picture and Specifications of Bio-Techne
Table Molecular Diagnostics Cancer Production, Price, Revenue and Gross Margin of 2018-2020
Figure Bio-Techne Molecular Diagnostics Cancer Market Share (2018-2020)
Table Bio-Techne Main Business
Table Bio-Techne Recent Development
Table of Appendix


More Publications